Eficacia del tratamiento con eritropoyetina humana recombinante (EPO-Hur) en niños anémicos con insuficiencia renal crónica (IRC). Experiencia de siete meses
M. Navarro, A. Alonso, J. Mª. Avila, E. Herrero y C. garcía Medeguer.
Leído
4606
Vecesse ha leído el artículo
2377
Total PDF
2229
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 59 | 87 | 146 |
| 2025 5 | 47 | 30 | 77 |
| 2025 4 | 37 | 22 | 59 |
| 2025 3 | 56 | 51 | 107 |
| 2025 2 | 40 | 36 | 76 |
| 2025 1 | 27 | 33 | 60 |
| 2024 12 | 19 | 11 | 30 |
| 2024 11 | 29 | 43 | 72 |
| 2024 10 | 30 | 23 | 53 |
| 2024 9 | 29 | 23 | 52 |
| 2024 8 | 32 | 38 | 70 |
| 2024 7 | 28 | 35 | 63 |
| 2024 6 | 29 | 28 | 57 |
| 2024 5 | 34 | 27 | 61 |
| 2024 4 | 28 | 34 | 62 |
| 2024 3 | 16 | 19 | 35 |
| 2024 2 | 16 | 35 | 51 |
| 2024 1 | 19 | 21 | 40 |
| 2023 12 | 17 | 12 | 29 |
| 2023 11 | 14 | 34 | 48 |
| 2023 10 | 21 | 29 | 50 |
| 2023 9 | 12 | 38 | 50 |
| 2023 8 | 16 | 19 | 35 |
| 2023 7 | 11 | 35 | 46 |
| 2023 6 | 20 | 20 | 40 |
| 2023 5 | 14 | 34 | 48 |
| 2023 4 | 12 | 34 | 46 |
| 2023 3 | 13 | 23 | 36 |
| 2023 2 | 11 | 26 | 37 |
| 2022 1 | 22 | 24 | 46 |
| 2022 12 | 18 | 29 | 47 |
| 2022 11 | 18 | 20 | 38 |
| 2022 10 | 17 | 39 | 56 |
| 2022 9 | 21 | 35 | 56 |
| 2022 8 | 18 | 30 | 48 |
| 2022 7 | 18 | 56 | 74 |
| 2022 6 | 14 | 25 | 39 |
| 2022 5 | 18 | 33 | 51 |
| 2022 4 | 14 | 30 | 44 |
| 2022 3 | 20 | 35 | 55 |
| 2022 2 | 14 | 41 | 55 |
| 2021 1 | 12 | 30 | 42 |
| 2021 12 | 15 | 33 | 48 |
| 2021 11 | 19 | 28 | 47 |
| 2021 10 | 11 | 42 | 53 |
| 2021 9 | 19 | 41 | 60 |
| 2021 8 | 14 | 53 | 67 |
| 2021 7 | 14 | 56 | 70 |
| 2021 6 | 7 | 24 | 31 |
| 2021 5 | 17 | 18 | 35 |
| 2021 4 | 17 | 67 | 84 |
| 2021 3 | 19 | 39 | 58 |
| 2021 2 | 45 | 27 | 72 |
| 2020 1 | 9 | 33 | 42 |
| 2020 12 | 11 | 27 | 38 |
| 2020 11 | 10 | 19 | 29 |
| 2020 10 | 10 | 25 | 35 |
| 2020 9 | 20 | 27 | 47 |
| 2020 8 | 12 | 23 | 35 |
| 2020 7 | 16 | 24 | 40 |
| 2020 6 | 14 | 14 | 28 |
| 2020 5 | 23 | 27 | 50 |
| 2020 4 | 15 | 46 | 61 |
| 2020 3 | 11 | 9 | 20 |
| 2020 2 | 16 | 36 | 52 |
| 2020 1 | 17 | 25 | 42 |
| 2019 12 | 20 | 23 | 43 |
| 2019 11 | 22 | 11 | 33 |
| 2019 10 | 18 | 1 | 19 |
| 2019 9 | 22 | 22 | 44 |
| 2019 8 | 22 | 32 | 54 |
| 2019 7 | 31 | 23 | 54 |
| 2019 6 | 45 | 19 | 64 |
| 2019 5 | 44 | 24 | 68 |
| 2019 4 | 72 | 37 | 109 |
| 2019 3 | 22 | 17 | 39 |
| 2019 2 | 15 | 17 | 32 |
| 2019 1 | 21 | 21 | 42 |
| 2018 12 | 22 | 11 | 33 |
| 2018 11 | 8 | 0 | 8 |
| 2018 10 | 9 | 3 | 12 |
| 2018 9 | 19 | 2 | 21 |
| 2018 8 | 6 | 0 | 6 |
| 2018 7 | 5 | 1 | 6 |
| 2018 6 | 9 | 1 | 10 |
| 2018 5 | 9 | 0 | 9 |
| 2018 4 | 8 | 0 | 8 |
| 2018 3 | 7 | 0 | 7 |
| 2018 2 | 4 | 0 | 4 |
| 2017 12 | 5 | 1 | 6 |
| 2017 11 | 4 | 1 | 5 |
| 2017 10 | 8 | 0 | 8 |
| 2017 9 | 3 | 0 | 3 |
| 2017 8 | 5 | 1 | 6 |
| 2017 7 | 4 | 3 | 7 |
| 2017 6 | 6 | 3 | 9 |
| 2017 5 | 4 | 2 | 6 |
| 2017 4 | 5 | 1 | 6 |
| 2017 3 | 7 | 3 | 10 |
| 2017 2 | 4 | 1 | 5 |
| 2016 1 | 9 | 1 | 10 |
| 2016 12 | 7 | 1 | 8 |
| 2016 11 | 5 | 0 | 5 |
| 2016 10 | 12 | 1 | 13 |
| 2016 9 | 12 | 1 | 13 |
| 2016 8 | 12 | 1 | 13 |
| 2016 7 | 27 | 1 | 28 |
| 2016 6 | 20 | 0 | 20 |
| 2016 5 | 32 | 0 | 32 |
| 2016 4 | 10 | 0 | 10 |
| 2016 3 | 24 | 0 | 24 |
| 2016 2 | 21 | 0 | 21 |
| 2015 1 | 11 | 0 | 11 |
| 2015 12 | 23 | 0 | 23 |
| 2015 11 | 27 | 0 | 27 |
| 2015 10 | 25 | 0 | 25 |
| 2015 9 | 19 | 0 | 19 |
| 2015 8 | 19 | 0 | 19 |
| 2015 7 | 16 | 0 | 16 |
| 2015 6 | 16 | 0 | 16 |
| 2015 5 | 26 | 0 | 26 |
Mostrar todo
